Does the angiotensin II type 1 receptor blocker candesartan attenuate graft vasculopathy?
Angiotensin II may play a role in the pathogenesis of transplant arteriosclerosis. Blockade of AT(1)R might be effective as a prophylactic therapy for transplant arteriosclerosis along with conventional immunosuppressive drugs.
This paper places particular emphasis on substantial gender-based differences in functional recovery of patients with their first-ever unilateral stroke.